Background: Foreign-born persons are considered at higher risk of undervaccination and exposure to many vaccine-preventable diseases. Information on vaccination coverage among foreign-born populations is limited.
Introduction
O verall, in 2011, an estimated 40 million foreignborn people (13% of the U.S. population) were living in the U.S., an increase compared with 1970 (5%). [1] [2] [3] The foreign born are individuals born outside of the U.S., Puerto Rico, and other U.S.-affiliated areas, such as Guam and the Marshall Islands who were not U.S. citizens at birth. 1 Although foreign-born populations are distributed throughout the U.S., in 2011, more than 25% lived in California and an additional 30% collectively lived in New York, Texas, and Florida. The foreign born from Latin America was the largest region-of-birth group, accounting for 53% of all foreign-born individuals, followed by 29% from Asia, 12% from Europe, and 7% from other regions. Most (65%) of the foreign born arrived in the U.S. before 2000. 1 Prevalence of most vaccine-preventable diseases (VPDs) in the U.S. are at or near record lows, but VPDs remain endemic in other world regions. Foreign-born persons from endemic countries and their family members in the U.S. are at greater risk of exposure for some VPDs (e.g., hepatitis A and B, congenital rubella) either pre-migration or during return trips to visit friends and family.
Foreign-born individuals, particularly those from Mexico, have been shown to have lower evidence of protective antibodies for some VPDs, possibly because of lack of vaccination, lower exposure, and waning immunity over time (e.g., tetanus, hepatitis B, varicella). 5, [7] [8] [9] [10] The Advisory Committee on Immunization Practices (ACIP) recommends vaccinations for adults in the U.S. to prevent VPDs and their sequelae. 11 Influenza vaccination is recommended for adults of all ages each year; other vaccines target different populations based on age, high-risk medical conditions, behavioral risk factors (e.g., injection drug use), occupation, travel, and other indications. 12, 13 Most foreignborn individuals originate from countries with different vaccination schedules and practices than the U.S. Despite significant improvements in global vaccination coverage in recent years, coverage remains low in many regions.
14 Even in the U.S., adult vaccination coverage remains low for most routinely recommended vaccines and well below Healthy People 2020 targets. 12, 13, 15 Analysis of two U.S. national surveys comparing vaccination coverage between foreign-born children and children of foreign-born mothers versus U.S.-born children and children of U.S.-born mothers, respectively, found disparities in vaccination levels of the foreign born for some vaccines (e.g., hepatitis B and Haemophilus influenzae type b) and advantages for others (e.g., pneumococcal conjugate vaccine and meningococcal conjugate vaccine). [6] [7] [8] [9] 16 Vaccination coverage disparities for foreignborn compared to native populations have been reported from Canada and several countries in Europe, Africa, and Asia. [17] [18] [19] [20] [21] [22] [23] A few studies in the U.S. have reported disparities in some vaccinations among foreign-born adults at national, state, or local levels. 8, [24] [25] [26] [27] However, comprehensive information on vaccination coverage on this population is limited. The purpose of this study is to examine coverage for certain routinely recommended adult vaccinations among the foreign born compared with U.S-born individuals, by selected demographic characteristics, to help guide development of strategies for improving vaccination coverage among foreign-born populations. 
Methods
Data from the 2012 National Health Interview Survey (NHIS) were analyzed in 2013. The NHIS is an annual household survey conducted by the National Center for Health Statistics, CDC, which collects health information on the U.S. civilian, noninstitutionalized population. 28 Detailed methods for the NHIS are described in other publications. 14, 28 In 2012, the final response rate for the sample adult core was 61.2%. 28 The NHIS has routinely collected influenza and PPV vaccination information since 1989. Starting in 2000, HepB vaccination information was collected. Staring in 2008, other vaccination information such as HepA, HPV, shingles, and Td/Tdap was collected.
Vaccination coverage by foreign-born status for influenza, PPV, tetanus toxoid-containing vaccines (Td, Tdap, or unknown type) in the past 10 years, HepA, HepB, shingles, and HPV vaccines were assessed from coded survey questions on receipt of these vaccines.
Covariates from coded survey questions to measure associations among vaccination coverage were selected: U.S.-born status, time in the U.S., language spoken during interview, world region of birth, racial/ethnic status, nativity, and citizenship status. HepA vaccination was assessed among those traveling to countries of high or intermediate endemicity. Persons with high-risk conditions for pneumococcal vaccination were determined by questions in the NHIS and defined as persons with asthma, diabetes, cardiovascular disease, liver diseases, kidney diseases, chronic obstructive pulmonary disease, emphysema, chronic bronchitis, cancer, and current smokers. Poverty status was defined using 2012 poverty thresholds published by the U.S. Census Bureau, with below poverty defined as a total family income of o$23,492 for a family of four. 29 Multivariable logistic regression and predictive marginals were conducted to assess vaccination coverage among U.S.-and foreignborn individuals adjusted for age, gender, race/ethnicity, marital status, education, employment status, poverty level, health insurance, number of doctor visits in the past year, whether the respondent had a usual place of health care, self-reported health status, and region of residence. Adjusted prevalence ratios were calculated comparing the U.S. and foreign born.
SUDAAN statistical software was used to calculate point estimates and 95% CIs of vaccination coverage. 30 SUDAAN generated asymmetric CIs based on a logit transformation were used. For the noninfluenza adult vaccination coverage estimates, weighted percentages were used. To better assess unadjusted influenza vaccination coverage for the 2011-2012 influenza season, the Kaplan-Meier survival analysis procedure was used to assess coverage among individuals interviewed from September 2011 through June 2012 and vaccinated during August 2011 through May 2012. 31 Kaplan-Meier analysis has advantages for season-specific influenza estimates over other approaches, such as using a full calendar year of data, or restricting estimates based on interviews conducted in the postvaccination period (e.g., March-June), which does not use all relevant data. 31 The Kaplan-Meier approach uses all relevant data to maximize precision and use data collected during the vaccination period that likely has more accurate recall of vaccinations. 31 To assess adjusted vaccination coverage and adjusted prevalence ratios, this study used logistic regression and predicted marginal modeling comparing the U.S. and foreign born for each selected vaccination. 
Results
Demographic characteristics of the study population are given in Table 1 . Of adults aged Z18 years, 82.6% were born in the U.S. and 17.4% were foreign born. Among the foreign born, 49.3% were from Mexico, Central America, or the Caribbean Islands; 22.7% from Asia; 12.3% from Europe; and 6.0% from South America (Table 1) .
Overall, vaccination coverage among U.S.-born respondents was significantly higher than that of foreign-born respondents ( ( Table 2) . Except for PPV vaccination of adults aged Z65 years, vaccination coverage among foreign-born adults who were U.S. citizens was significantly higher than that for foreign-born respondents who were not U.S. citizens (po0.05). Among U.S.-born respondents who preferred to be interviewed in a non-English language, vaccination coverage was significantly lower for influenza, tetanus, and HPV vaccination for women aged 18-26 years, compared with coverage among those who preferred to be interviewed in English (Table 3) . Among the foreign born, coverage was significantly lower for all vaccinations among those who preferred to be interviewed in a language other than English compared with those who preferred English for the interview.
Among the U.S. born, coverage for most vaccinations was significantly lower for non-Hispanic blacks and Hispanics compared with non-Hispanic whites (Table 4) . Among the foreign born, Hispanics had significantly lower coverage for most vaccinations compared with non-Hispanic whites, whereas non-Hispanic blacks had significantly lower vaccination coverage only for Td (Table 4) . Among all race/ ethnic-nativity groups, Hispanic foreign born had the lowest coverage for several vaccines, including influenza, Tdap, HepA, HepB (age 18-49 years), and shingles.
Vaccination coverage by foreign birth region varied across vaccines compared with those born in the U.S. (Table 5 ). Except for HepB vaccination (age Z18 years with diabetes), adult vaccination coverage was significantly lower among those who were born in Mexico, Central America, or the Caribbean Islands, compared with those who were born in the U.S. Coverage was lower for those born in Europe compared with coverage among those born in the U.S. for PPV and overall tetanus vaccination, but was higher for HepB vaccination for adults aged Z18 years with diabetes (40.4% vs 20.8%, respectively) and similar for other vaccines. Among those who were born in Asia, coverage was lower for PPV (age Z65 years), overall tetanus and Tdap vaccinations, and shingles vaccination, but was higher for HepB vaccination (age Z18 years with diabetes; 34.5% vs 20.8%, respectively). After adjusting for confounders, foreign-born adults aged Z65 years were less likely to receive pneumococcal vaccination than the U.S. born, and foreign-born adults aged Z18 years were less likely to receive tetanus or Tdap vaccination than the U.S. born (Table 6) . Foreign-born women aged 18-26 years were less likely to receive HPV vaccination than U.S.-born women (Table 6 ).
Discussion
This is the first comprehensive assessment of vaccination coverage among foreign-born adults in the U.S. Overall, vaccination coverage is generally lower among the foreign-born compared with U.S.-born individuals, even after adjusting for confounders for pneumococcal, tetanus, Tdap, and HPV vaccines. Vaccination coverage for the foreign born differs by time lived in the U.S., citizenship status, language used for interview, race/ ethnicity, and birth country/region. Among the foreign born, vaccination coverage is generally lower among non-U.S. citizens, those interviewed in a language other than English, and non-Hispanic blacks or Hispanics compared with U.S. citizens, those interviewed in English, and non-Hispanic whites. The Hispanic foreign born have the lowest coverage for several vaccines. This finding is particularly relevant because the foreign born from Latin America account for more than half of all foreign-born adults in the U.S. [1] [2] [3] Vaccination coverage among the foreign born in the U.S. depends on the vaccinations received as children or adults pre-migration, during migration, post-migration, or during return visits to their country of origin. Vaccination coverage and immunization schedules vary by country and even by regions within countries. 11, 14, 32 For example, the adult vaccination schedules in Mexico are different compared with the U.S. (e.g., influenza: people aged Z60 years, pregnant women, and people with risk factors [Mexico] versus universal vaccination [U.S.]; PPV: people aged Z60 years with high-risk conditions and those aged Z65 years versus people aged 18-64 years with high-risk conditions and those aged Z65 years; Tdap: pregnant women versus people aged Z18 years; HepA: no adult recommendation versus people with high-risk behaviors and those traveling to a country of high or intermediate endemicity; HepB: no adult recommendation versus people with high-risk behaviors, those with diabetes, and healthcare personnel; HPV: no adult recommendation versus people aged 18-26 years; and shingles: no adult recommendation versus people aged Z60 years). 11, 33 The differences between the U.S. and other countries in the schedules of routine vaccinations among adults may contribute to differences in the coverage levels of the studied vaccines. In most countries, immunization programs have historically focused on children.
34-36
Depending on their origin, age at arrival, and year of arrival, foreign-born adults may be likely to have differences in vaccination coverage compared with U.S.-born populations when they arrive in the U.S. 10, 24 After arrival in the U.S., many foreign-born adults experience socioeconomic, cultural, linguistic, and other barriers to accessing health care and preventive services, including immunizations. 1, 2, 37 The percentage of uninsured is higher among non-U.S. citizens, recent immigrants, and those with poor/fair English proficiency. 3, 38 The study findings of lower vaccination coverage for non-citizens, recent immigrants, and those interviewed in a language other than English are not unexpected. These characteristics are closely associated with lower access to care. 3 These populations may also be less aware of U.S. adult immunization recommendations. 39 The finding of disparities in vaccination coverage for non-English speakers also has been reported previously. [40] [41] [42] [43] [44] [45] [46] Limited English proficiency has been reported to be an impediment to accessing health services and health promotion programs. 40, 44 Disparities in influenza and pneumococcal immunizations among older adults have been reported for those speaking Spanish at home, 40 those with limited English fluency, Hispanic Spanish speakers versus Hispanic English speakers, [41] [42] [43] [44] [45] and those not having English as their primary language, [40] [41] [42] [43] [44] [45] independent of many demographic, access-to-care, and other factors. 43 The findings in this report are subject to one limitation. Adult vaccination coverage was self-reported and therefore might be subject to recall bias. However, self-reported influenza, PPV, tetanus, HepA, HepB, shingles, and HPV vaccination status among adults have been shown to be sensitive and specific for all except tetanus. [47] [48] [49] [50] [51] This study confirms the low adult vaccination coverage in the U.S. and documents significant disparities for foreign-born populations. These disparities are even more relevant because immigration is projected to become the principal driver of U.S. population growth and racial/ ethnic diversity. 1, 3, 52 Even when no disparities are identified (e.g., HepB), the low overall vaccination coverage is more worrisome for some foreign-born populations because of their higher risk of exposure to certain VPDs. 24 Any comprehensive adult vaccination strategy, particularly among the foreign born, needs to be tailored to the needs of the target populations and the capacity of public health and healthcare institutions to address their vaccination needs. 53, 54 Access-to-care factors play an important role in vaccination uptake. [55] [56] [57] [58] Routine assessment of patient vaccination histories, recommendations, and offers of needed vaccinations should be incorporated into routine clinical care of adults. 53, 54, 59 Ensuring standing orders are in place to reduce the number of missed opportunities of individuals who have already accessed healthcare system and enhancing reminder and recall systems for patients and providers are proven strategies to improve adult vaccination coverage. 54 Increasing healthcare providers' awareness about foreign-born vaccination disparities and best practices for addressing them is particularly important. 54 Given the high proportion of the foreign born with limited access to health care in the U.S., alternative, targeted outreach strategies have been recommended, 60 including offering vaccinations at non-traditional settings (e.g., ethnic fairs, migrant camps, workplaces). Community leaders, organizations, and community health workers serving foreign-born adults may be empowered to disseminate linguistic and culturally sensitive vaccination information. Access to low-cost or free vaccinations may be especially important for this population because of its limited economic resources 60 and high rate of uninsurance. All foreign-born individuals, irrespective of their immigration status, are eligible for public health programs providing vaccinations. 37, [61] [62] [63] However, other factors, such as limited local health department funding for vaccinations or immigrants' lack of awareness of their eligibility for those programs, may in practice restrict their use.
The Immigration and Nationality Act 64 and guidelines from CDC promote vaccinations among certain foreignborn populations. All foreign citizens applying for a permanent resident visa while overseas (482,000 in 2011) or adjusting status when already in the U.S. (580,000 in 2011) are required to show proof of having received all required vaccinations or otherwise must receive the first dose for each vaccine series. 65 Immigration-required vaccination, however, does not apply to unauthorized immigrants (11 million in 2011), those admitted with temporary worker visas (3.8 million in 2011), and international students and exchange visitors (2.3 million in 2011). 66 Several provisions of the Affordable Care Act (ACA) might improve access to healthcare services and ACIP-recommended vaccinations for some immigrants who were previously without health insurance. 67 However, unauthorized immigrants are excluded from the ACA and several large categories of foreign-born legal residents have restrictions in their eligibility for the federal Medicaid program. 68 Collaboration with immunization programs in countries of origin for targeted outreach and monitoring of migrants would also improve vaccination coverage among the foreign born.
Currently, some national surveys used in vaccination coverage monitoring collect little or no data related to foreign-born persons, limiting assessment disparities in this population. Strategies to increase inclusion of the foreign born in surveys include adding or expanding migration-related variables on surveys, ensuring data collection instruments are available for the main foreign languages spoken in the U.S., making translators available, and collaborating with leaders and organizations trusted by foreign-born communities. 42, 53, 54, 60, 69, 70 As the size and race/ethnic diversity of the foreignborn population in the U.S. continues to increase, the findings of this study indicate that this population will be increasingly important to elimination of national adult vaccination disparities. 6 Public policy makers, immunization programs, and healthcare providers should consider foreign-born populations in their public health assessment, evaluation, and outreach programs that target disadvantaged groups.
